Sponsor
Fujian Medical University Union Hospital
Clinical research sponsor
How to interpret these research links
Connected source recordsThe exact organization name Fujian Medical University Union Hospital appears in 54 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
54 shownTubeless Anesthesia in Preventing Lung Complications in Patients Undergoing Surgery for Early-Stage Lung CancerNCT07024433 · lead sponsor · 2025-05-25
RECRUITINGEfficacy and Safety of Transcranial Magnetic Stimulation in Treatment of Alzheimer's DiseaseNCT07324161 · lead sponsor · 2025-04-16
RECRUITINGInternal Mammary Lymph Nodes Irradiation in High-risk Breast Cancer After Neoadjuvant ChemotherapyNCT06559696 · lead sponsor · 2024-07-15
RECRUITINGIntegrated Digital and Neurogenic Exosome Biomarkers for Early Diagnosis of Parkinson's Disease: Development and ApplicationNCT07679256 · lead sponsor · 2024-01-01
RECRUITINGPersonalized Optimization of Systematic Prostate BiopsyNCT05998278 · lead sponsor · 2023-08-23
RECRUITINGPirfenidoneVsPlacebo as Prophylaxis Against Acute Radiation-induced Lung Injury Following HFRT in Breast Cancer PatientsNCT05704166 · lead sponsor · 2023-03-16
RECRUITINGCompare Continuation of Original Targeted Therapy With Trastuzumab Combined With Pyrotinib and Capecitabine as Postoperative Adjuvant Therapy in Non-pCR Patients With HER2 Positive Early Breast CancerNCT05292742 · lead sponsor · 2021-07-02
RECRUITINGA Multimodal Convergent Cohort of Parkinson's Disease at FJMUUH (FJMUUH-PD): Natural History StudyNCT07588763 · lead sponsor · 2026-04-28
NOT_YET_RECRUITINGRezvilutamide for High-Risk Prostate Cancer After SurgeryNCT07444983 · lead sponsor · 2026-02-11
NOT_YET_RECRUITINGPercutaneous Robotic Navigation Microwave Ablation Versus CT-guided Microwave Ablation in the Treatment of Pulmonary Nodules With Ground-glass OpacityNCT07389889 · lead sponsor · 2026-02-01
NOT_YET_RECRUITINGThe Improvement Effect of Henggliejin on Fatty Liver in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver:NCT07198516 · lead sponsor · 2025-11-01
NOT_YET_RECRUITINGEffects of Different Preoperative Oral Rehydration Protocols in Undergoing Thoracoscopic Radical Lung Cancer SurgeryNCT07042503 · lead sponsor · 2025-07-01
NOT_YET_RECRUITINGEfficacy and Safety of Ensartinib in Neoadjuvant Therapy for Stage IIA - IIIB (Operable or Potentially Operable) ALK-Positive Lung Adenocarcinoma ：A Multicenter, Real-World Clinical StudyNCT06785584 · lead sponsor · 2025-02-01
NOT_YET_RECRUITINGApplication of Targeted Axillary Lymph Node Resection in Axillary Surgery After Neoadjuvant Chemotherapy for Breast Cancer: an Open-label, Multicenter StudyNCT07032220 · lead sponsor · 2024-12-09
ACTIVE_NOT_RECRUITINGEffect of Neoadjuvant Chemotherapy on Cardiac Function of Perioperative Patients With Breast Cancer and New Strategies for AnesthesiaNCT06497660 · lead sponsor · 2024-08-01
UNKNOWNStudy of the Effects of STN-DBS on Gait in Parkinson's Disease.NCT06418802 · lead sponsor · 2024-06-01
UNKNOWNEfficacy, Safety and Response Predictors of Astragalus Membranaceus on the Improvement of Cognitive Function in Mild-to-Moderate Alzheimer's DiseaseNCT05578443 · lead sponsor · 2024-05-01
UNKNOWNEfficacy, Safety and Response Predictors of Adjuvant Astragalus for Cognition in Orthostatic HypotensionNCT05647473 · lead sponsor · 2024-02-20
UNKNOWNChemotherapy-immunotherapy-based Split-course Adaptive Hypofractionated Radiotherapy for Extensive-stage SCLCNCT06816966 · lead sponsor · 2023-12-26
ENROLLING_BY_INVITATIONPostoperative Chronic Operation-related Symptoms After Minimally Invasive Lung SurgeryNCT06016881 · lead sponsor · 2023-08-18
UNKNOWNEfficacy, Safety of Astragalus Membranaceus in Mild-to-Moderate Alzheimer's DiseaseNCT06694597 · lead sponsor · 2023-05-01
COMPLETEDNMR Based Metabolomic Study of Serum Biomarkers in Patients With Parkinson's Disease and Atypical Parkinsonian SyndromeNCT06490926 · lead sponsor · 2023-02-01
UNKNOWNTiming of Surgery and the Evolution of Postoperative Outcomes in Breast Cancer Patients Undergoing Surgical Intervention Following Recovery From SARS-CoV-2 InfectionNCT06319209 · lead sponsor · 2023-01-01
UNKNOWNDalpiciclib Plus Letrozole and CapecitabineNCT05469750 · lead sponsor · 2022-08-10
UNKNOWNPyrotinib Plus Trastuzumab After First-line TH (P) Treatment With HER-2 Positive Breast CancerNCT05255523 · lead sponsor · 2022-02-20
UNKNOWNApplication of Preoperative Axillary Lymph Node Marking With Nano-Carbon in Breast Cancer Patients Before Neoadjuvant ChemotherapyNCT05512468 · lead sponsor · 2020-03-01
UNKNOWNEffect of Optimal Positive End-Expiratory Pressure on Oxygenation and Intrapulmonary Shunt During One-lung VentilationNCT03804398 · lead sponsor · 2018-06-14
COMPLETEDEffect of Preoperative Budesonide Inhalation on Arterial Blood Oxygenation and Intrapulmonary Shunt During OLVNCT03394222 · lead sponsor · 2016-07-01
COMPLETEDRelationship Between Genetic Polymorphism and Postoperative Nausea and Vomiting in Chinese Han PopulationNCT03705026 · lead sponsor · 2013-09-01
COMPLETEDImpact of a Predictive Model on Sentinel Lymph Node Biopsy in Initially Lymph Node-positive, HER2-positive Breast CancerNCT06149377 · lead sponsor · 2012-04-01
COMPLETEDRATS Sleeve Lobectomy After Neo-Chemo-IO for NSCLCNCT07541521 · collaborator · 2026-04-13
RECRUITINGDownstaging and RATS After Neo-Chemo-IO: Impact on Surgical Outcomes in NSCLCNCT07528066 · collaborator · 2026-03-02
RECRUITINGOzanimod in Patients With Alzheimer's DiseaseNCT06862960 · collaborator · 2025-08-13
RECRUITINGThe Application of "HUAXI Hole 1" in Reverse-sequence Endoscopic Nipple-sparing Mastectomy With Direct-to-implant Breast ReconstructionNCT06995118 · collaborator · 2025-06-17
RECRUITINGAI-Enhanced Optimization of Acute Levodopa Challenge TestNCT06949865 · collaborator · 2024-05-28
RECRUITINGA Randomized Controlled Trial of LOT-CRT Versus conventionaL BiVP in Heart Failure Patients With NICDNCT06061627 · collaborator · 2023-09-21
RECRUITINGPARP Inhibitor With CDK4/6 Inhibitor and Endocrine Therapy in HR+/ HER2-Advanced Breast CancerNCT05759546 · collaborator · 2023-02-01
RECRUITINGSNF Platform Study of HR+/ HER2-advanced Breast CancerNCT05594095 · collaborator · 2022-12-30
RECRUITINGThe Chinese Familial Alzheimer's NetworkNCT03657732 · collaborator · 2005-01-10
RECRUITINGChina Cognition and Aging StudyNCT03653156 · collaborator · 2000-01-01
RECRUITINGMultimodal Risk Factor Graph Mapping, Metabolic Subtyping, and Digital Intelligent Chronic Disease Management for Prediabetes: An Integrated Cohort and Case-Control Clinical StudyNCT07854002 · collaborator · 2026-10-08
NOT_YET_RECRUITINGDrain Removal on Postoperative Safety and Patient Satisfaction in R-E-NSM With Prepectoral DIBRNCT07237828 · collaborator · 2025-12-01
NOT_YET_RECRUITINGPARP Inhibitor With CDK4/ 6 Inhibitor and Endocrine Therapy in HR+/ HER2-Advanced Breast CancerNCT06612814 · collaborator · 2024-09-01
ACTIVE_NOT_RECRUITINGEffectiveness and Safety of Using Prontosan to Treat Bacterial BiofilmNCT06185465 · collaborator · 2024-01-03
UNKNOWNLobectomy-First vs. Lymphadenectomy-First for Operable NSCLC (LOFTY)NCT06577792 · collaborator · 2023-08-16
ACTIVE_NOT_RECRUITINGApatinib With CDK4/6 Inhibitor and Endocrine Therapy in HR+/ HER2- Advanced Breast CancerNCT05759572 · collaborator · 2023-03-01
ACTIVE_NOT_RECRUITINGEfficacy and Safety of Rasagiline in Prodromal Parkinson's DiseaseNCT05611372 · collaborator · 2023-01-01
WITHDRAWNLBBP as Initial Therapy in Patients With Non-ischemic Heart Failure and LBBBNCT05572957 · collaborator · 2022-10-14
ACTIVE_NOT_RECRUITINGImmune Therapy in HR-positive/HER2-negative Metastatic Breast Cancer(ENIGMA)-BCTOP-L-M02NCT05205200 · collaborator · 2022-06-06
UNKNOWNTreatment of EGFR-TKI for Residual Lesions of Multiple Synchronous Ground-glass OpacitiesNCT04982900 · collaborator · 2021-10-01
UNKNOWNHRCT in Prediction of Tumor Invasion in GGO Lung Adenocarcinoma (ECTOP-1008)NCT04165759 · collaborator · 2019-11-18
COMPLETEDMultifactorial Intervention on Diabetes (MIDiab Study)NCT03430284 · collaborator · 2018-04-01
UNKNOWNSublobar Resection Versus Lobectomy for cT1N0M0 Non-small-cell Lung CancerNCT03108560 · collaborator · 2017-04-18
UNKNOWNErlotinib Versus Gemcitabine/Cisplatin as (Neo)Adjuvant Treatment in Non-small Cell Lung CancerNCT01407822 · collaborator · 2011-12-05
UNKNOWNDrugs studied in this sponsor's trials
10 mapped RxNorm conceptsThese drug records are connected through ClinicalTrials.gov studies listing Fujian Medical University Union Hospital as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.
bevacizumab1
ensartinib1
erlotinib1
everolimus1
goserelin1
ozanimod1
paclitaxel protein-bound1
placebo1
bevacizumab RxCUI 253337 · Lead sponsor in 0 linked trial(s) · 1 currently recruiting
1 trial
ensartinib RxCUI 2712546 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
erlotinib RxCUI 337525 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
1 trial
everolimus RxCUI 141704 · Lead sponsor in 0 linked trial(s) · 1 currently recruiting
1 trial
goserelin RxCUI 50610 · Lead sponsor in 0 linked trial(s) · 1 currently recruiting
1 trial
ozanimod RxCUI 2288236 · Lead sponsor in 0 linked trial(s) · 1 currently recruiting
1 trial
paclitaxel protein-bound RxCUI 486610 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
1 trial
placebo RxCUI 8375 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
1 trial
rasagiline RxCUI 134748 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
1 trial
sorafenib RxCUI 495881 · Lead sponsor in 0 linked trial(s) · 1 currently recruiting
1 trial
Sponsor roles
lead sponsor30
collaborator24
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.